Which has grown faster, CRBU or MXCT?

Over the past five years, MXCT grew revenue faster — CRBU at a -2.03% CAGR versus MXCT at 1.46%.

How have CRBU and MXCT total returns compared?

Over the past 5 years, CRBU delivered -44.43% and MXCT delivered -37.32% annualized total return. Past performance doesn't predict future results.

Caribou Biosciences, Inc. (CRBU) vs MaxCyte, Inc. (MXCT)

A side-by-side comparison of Caribou Biosciences, Inc. and MaxCyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CRBU

Caribou Biosciences, Inc.

$115M

$1.16HealthcareDelayed quote: Oct 6, 2026, 1:59 PM EDT

MXCT

MaxCyte, Inc.

$113M

$1.06HealthcareDelayed quote: Oct 6, 2026, 1:53 PM EDT

Total return — CRBU vs MXCT

growth of $100 · dividends reinvested · last 5y

CRBU -92.5% (-40.4%/yr)MXCT -93.6% (-42.4%/yr)CRBU compounded faster over this window

CRBU MXCT

CRBU vs MXCT: by the numbers

•CRBU is the larger company ($115M vs $113M market cap).
•Both run net losses; MXCT's is the smaller (-114.77% vs -1030.42% net margin).
•MXCT grew revenue faster over the past five years (1.46% vs -2.03% CAGR).

Metrics side by side

Valuation

Metric	CRBU	MXCT
P/S ratio	11.42	3.64
P/B ratio	1.17	0.71

Profitability

Metric	CRBU	MXCT
Gross margin	67.34%	79.43%
Operating margin	-1220.49%	-137.12%
Net margin	-1030.42%	-114.77%
ROE	-105.40%	-22.45%
ROIC	-87.72%	-19.83%

Growth (annualized)

Metric	CRBU	MXCT
Revenue CAGR (5Y)	-2.03%	1.46%
Total return CAGR (5Y)	-44.43%	-37.32%

Frequently asked

Which has grown faster, CRBU or MXCT?: Over the past five years, MXCT grew revenue faster — CRBU at a -2.03% CAGR versus MXCT at 1.46%.
How have CRBU and MXCT total returns compared?: Over the past 5 years, CRBU delivered -44.43% and MXCT delivered -37.32% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CRBU analysis Full MXCT analysis Interactive comparison tool

Dig into the metrics

Caribou Biosciences ROE MaxCyte ROE Caribou Biosciences operating margin MaxCyte operating margin Caribou Biosciences revenue growth MaxCyte revenue growth Caribou Biosciences free cash flow MaxCyte free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.